Showing results (1-10 of 67) with videos related to
Sort By:
Pageof 7
Journal of Child Neurology|August 15, 2002
Central nervous system prophylaxis with high-dose methotrexate does not give rise to significant electroencephalographic changes in children with acute lymphoblastic leukemiaRudolf Korinthenberg, Annette Schneider, Charlotte NiemeyerMedical and Pediatric Oncology|October 12, 2002
On the origin of EEG-slowing and encephalopathy during induction treatment of acute lymphoblastic leukemiaRudolf Korinthenberg, Bernadette Scheuring, Joachim Boos, et al.Orphanet Journal of Rare Diseases|October 17, 2022
Pearson syndrome: a multisystem mitochondrial disease with bone marrow failureAyami Yoshimi, Kaori Ishikawa, Charlotte Niemeyer, et al.Leukemia & Lymphoma|May 27, 2004
Marked thrombocytosis in a child with advanced myelodysplastic syndromeAlexander Claviez, Bona Ngoumou, Lana Harder, et al.Frontiers in Pediatrics|November 28, 2022
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AMLFranziska Schmidt, Miriam Erlacher, Charlotte Niemeyer, et al.Pediatric Blood & Cancer|August 29, 2025
Two Cases of Juvenile Myelomonocytic Leukemia With Identical Somatic PTPN11 Mutations in Children After In Utero Exposure to Thiopurine-Containing ChemotherapyMarek Ussowicz, Monika Rosa, Monika Biedroń, et al.The Cochrane Database of Systematic Reviews|August 6, 2010
Deferasirox for managing transfusional iron overload in people with sickle cell diseaseJoerg J Meerpohl, Gerd Antes, Gerta Rücker, et al.European Journal of Pediatrics|May 13, 2004
Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndromeSabine Dormann, Marcus Krüger, Roland Hentschel, et al.Pediatric Hematology and Oncology|August 22, 2007
Biotinidase deficiency and juvenile myelomonocytic leukemia in a Turkish infant of consanguineous parentsSevgi Yetgin, Selin Aytac, Serap Kalkanoglu, et al.European Journal of Haematology|June 9, 2004
WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?Peter Bader, Charlotte Niemeyer, Gerrit Weber, et al.Pageof 7